Physician

Gregory L Salzman, M.D.

According to 2025 Medicare claims, Gregory Salzman, M.D. (NPI: 1821095456) practices gastroenterology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Dearborn, IN. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP, INC (NPI: 1750343216; TIN: 611300608) and primary practice location at 47025-2751. Salzman is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Salzman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 506 traditional Medicare patients, billed 1,491 HCPCS/CPT codes, and received $119,348 in Medicare payments. The top billing code was 45380 (Biopsy of large bowel using a flexible endoscope). Part D data shows 3,790 prescription claims across 875 beneficiaries totaling $2,648,156 in drug costs, led by Gattex (Teduglutide). 2020 DME data shows 13 claims. Open Payments data shows 142 records totaling $2,344. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $221,441 to $119,348. In contrast, Part D prescription costs have risen steadily, from $1,269,240 to $2,648,156. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	829	3,613	$221,441
2016	885	2,751	$175,771
2017	843	2,158	$161,958
2018	815	15,626	$170,212
2019	834	4,243	$154,670
2020	715	1,692	$124,692
2021	736	8,663	$157,001
2022	694	8,928	$204,657
2023	544	1,610	$132,262
2024	506	1,491	$119,348

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	793	4,146	$1,269,240
2016	866	4,226	$1,529,221
2017	924	4,447	$1,612,293
2018	945	4,781	$2,012,727
2019	1,012	4,872	$1,912,917
2020	1,008	4,919	$1,868,601
2021	1,025	4,928	$2,193,525
2022	1,073	4,856	$2,038,077
2023	1,102	3,679	$2,231,777
2024	875	3,790	$2,648,156

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	40	$3,590
2016	N/R	11	$1,242
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	13	$633
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45380	Biopsy of large bowel using a flexible endoscope	115	116	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	141	186	$88
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	91	91	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	131	148	$62
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	224	248	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gattex	Teduglutide	19	570	$850,211
Sucraid	Sacrosidase	34	1,079	$496,904
Xifaxan	Rifaximin	41	1,214	$133,398
Linzess	Linaclotide	123	6,930	$123,980
Rinvoq	Upadacitinib	13	382	$104,112

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	142	$2,344	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gregory L. Salzman, M.D.?

Tedicare shows public-source Medicare data for Gregory L. Salzman, M.D. (NPI 1821095456), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory L. Salzman, M.D. have ACO affiliation data?

Gregory L. Salzman, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Gregory L. Salzman, M.D.?

Gregory L. Salzman, M.D. is linked to SUMMIT MEDICAL GROUP, INC (billing NPI 1750343216) in the available physician profile data.

Does Gregory L. Salzman, M.D. have Open Payments data?

Gregory L. Salzman, M.D. has 142 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.